Article

Predictive power of different <i>Akkermansia</i> phylogroups in clinical response to PD-1 blockade against non-small cell lung cancer

2024-08-22

Abstract excerpt

<h4>Summary</h4> Immune checkpoint blockade has emerged as a promising form of cancer therapy. However, only some patients respond to checkpoint inhibitors, while a significant proportion of patients do not, calling for the discovery of reliable biomarkers. Recent studies reported the importance of the gut microbiome in the clinical response to PD-1 blockade against non-small cell lung cancer (NSCLC), highlightin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 26d7a4e4-2252-5140-8cbc-f44455a576f0
DOI: 10.1101/2024.08.21.608814

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Predictive power of different <i>Akkermansia</i> phylogroups in clinical response to PD-1 blockade against non-small cell lung cancerDOI 10.1101/2024.08.21.608814Read

Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcomeSemantic proximity Read

Gut microbial signature in lung cancer patients highlights specific taxa as predictors for durable clinical benefitSemantic proximity Read

Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancerSemantic proximity Read

Gut microbiome metabolites, molecular mimicry, and species-level variation drive long-term efficacy and adverse event outcomes in lung cancer survivorsSemantic proximity Read

Gut microbial structural variation associates with immune checkpoint inhibitor responseSemantic proximity Read

A gut microbial signature for combination immune checkpoint blockade across cancer typesSemantic proximity Read

Microbiome landscape and association with response to immune checkpoint inhibitors in advanced solid tumors: SCRUM-Japan MONSTAR-SCREENSemantic proximity Read

Akkermansia muciniphila: A potential target and pending issues for oncotherapySemantic proximity Read

Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-PD-1 Therapy in Chinese Non-Small Cell Lung Cancer PatientsSemantic proximity Read

Gut Metatranscriptomics Based De Novo Assembly Reveals Microbial Signatures Predicting Immunotherapy outcomes in Non-Small Cell Lung CancerSemantic proximity Read

Pan-cancer analysis reveals tumor microbiome associations with host molecular aberrationsSemantic proximity Read

A conserved pilin from uncultured gut bacterial clade TANB77 enhances cancer immunotherapySemantic proximity Read